510(k) K160570
K160570 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations (Rdo) for the device "Creatine Kinase". The FDA issued a decision of Substantially Equivalent on May 25, 2016. The device falls under product code JHS (Differential Rate Kinetic Method, Cpk Or Isoenzymes), a Class II device regulated under 21 CFR 862.1215. Roche Diagnostics Operations (Rdo) has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 25, 2016
- Date Received
- February 29, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Differential Rate Kinetic Method, Cpk Or Isoenzymes
- Device Class
- Class II
- Regulation Number
- 862.1215
- Review Panel
- CH
- Submission Type